|
|
||||||||
Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago, Chicago, Illinois 60637; and Krankenhaus Grosshansdorf, Grosshansdorf, Germany
Hypertrophy and
hyperplasia lead to excess accumulation of smooth muscle in the airways
of human asthmatic subjects. However, little is known about mechanisms
that might counterbalance these processes, thereby limiting the
quantity of smooth muscle in airways. Ligation of Fas on the surface of
vascular smooth muscle cells and nonmuscle airway cells can lead to
apoptotic cell death. We therefore tested the hypotheses that
1) human airway smooth muscle (HASM) expresses Fas, 2)
Fas cross-linking induces apoptosis in these cells, and 3)
tumor necrosis factor (TNF)-
potentiates Fas-mediated airway myocyte
killing. Immunohistochemistry using CH-11 anti-Fas monoclonal IgM
antibody revealed Fas expression in normal human bronchial smooth
muscle in vivo. Flow cytometry using DX2 anti-Fas monoclonal IgG
antibody revealed that passage 4 cultured HASM cells express
surface Fas. Surface Fas decreased partially during prolonged serum
deprivation of cultured HASM cells and was upregulated by TNF-
stimulation. Fas cross-linking with CH-11 antibody induced apoptosis in
cultured HASM cells, and this effect was reduced by long-term serum
deprivation and synergistically potentiated by concomitant TNF-
exposure. TNF-
did not induce substantial apoptosis in the absence
of Fas cross-linking. These data represent the first demonstration that
Fas is expressed on HASM and suggest a mechanism by which Fas-mediated
apoptosis could act to oppose excess smooth muscle accumulation during
airway remodeling in asthma.
asthma; airway remodeling; cytokines
This article has been cited by other articles:
![]() |
S. Salinthone, M. Ba, L. Hanson, J. L. Martin, A. J. Halayko, and W. T. Gerthoffer Overexpression of human Hsp27 inhibits serum-induced proliferation in airway smooth muscle myocytes and confers resistance to hydrogen peroxide cytotoxicity Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1194 - L1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. An, T. R. Bai, J. H. T. Bates, J. L. Black, R. H. Brown, V. Brusasco, P. Chitano, L. Deng, M. Dowell, D. H. Eidelman, et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma Eur. Respir. J., May 1, 2007; 29(5): 834 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Solway and C. G. Irvin Airway Smooth Muscle as a Target for Asthma Therapy N. Engl. J. Med., March 29, 2007; 356(13): 1367 - 1369. [Full Text] [PDF] |
||||
![]() |
S. Lajoie-Kadoch, P. Joubert, S. Letuve, A. J. Halayko, J. G. Martin, A. Soussi-Gounni, and Q. Hamid TNF-{alpha} and IFN-{gamma} inversely modulate expression of the IL-17E receptor in airway smooth muscle cells Am J Physiol Lung Cell Mol Physiol, June 1, 2006; 290(6): L1238 - L1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Oltmanns, M. B. Sukkar, S. Xie, M. John, and K. F. Chung Induction of Human Airway Smooth Muscle Apoptosis by Neutrophils and Neutrophil Elastase Am. J. Respir. Cell Mol. Biol., April 1, 2005; 32(4): 334 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Patel, M. G. Belvisi, D. Bishop-Bailey, M. H. Yacoub, and J. A. Mitchell Activation of Peroxisome Proliferator-Activated Receptors in Human Airway Smooth Muscle Cells Has a Superior Anti-inflammatory Profile to Corticosteroids: Relevance for Chronic Obstructive Pulmonary Disease Therapy J. Immunol., March 1, 2003; 170(5): 2663 - 2669. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. A. JOHNSON, M. ROTH, M. TAMM, M. HUGHES, Q. GE, G. KING, J. K. BURGESS, and J. L. BLACK Airway Smooth Muscle Cell Proliferation Is Increased in Asthma Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 474 - 477. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |